Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05766735 · ClinicalTrials.gov registry record · NA

Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification

A NA study of Type 2 Diabetes, sponsored by Chiara Fabris, PhD.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
2
Study locations

NCT05766735: Recruiting NA study of Type 2 Diabetes, sponsored by Chiara Fabris, PhD.

NCT05766735 is a NA study of Type 2 Diabetes that is actively recruiting participants, run by Chiara Fabris, PhD. The registered enrollment target is 200 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05766735, a NA study of Type 2 Diabetes, is actively recruiting participants, sponsored by Chiara Fabris, PhD.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
2
Study locations

Study Summary

A Randomized Control Trial (RCT) with 1:1 randomization of adults newly diagnosed with type 2 diabetes (T2D) to Routine Care (RC) and RC + Glycemic Excursion Minimization (RC+GEM); a program that provides RC in addition to continuous glucose monitors (CGM) within a structured, self-directed, and personalized lifestyle program called GEM. Our hypothesis is that RC+GEM will: 1) reduce hemoglobin A1c as much or more, 2) require less diabetes medication, 3) cost less, and 4) have more secondary benefits, (e.g. greater reduction in cardiovascular risk, weight, diabetes distress, depression symptoms), compared to RC alone.

Conditions Studied

Type 2 Diabetes

Interventions

  • BEHAVIORAL Routine Care + Glycemic Excursion Minimization (RC+GEM)
  • OTHER Routine Care (RC)

Study Locations (2)

Colorado

  • University of Colorado Department of Family Medicine - Aurora

Virginia

  • University of Virginia Center for Diabetes Technology - Charlottesville

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2023-08-08
Est. Completion 2027-04-15
Phase NA

Sponsor

Chiara Fabris, PhD

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05766735

The ClinicalTrials.gov registry entry for NCT05766735 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (82% lower). The listed sponsor is Chiara Fabris, PhD, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Routine Care + Glycemic Excursion Minimization (RC+GEM) is the first listed.

NCT05766735 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Colorado, Virginia.

Frequently Asked Questions

What is clinical trial NCT05766735 about?

NCT05766735 is a clinical study titled "Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification". A Randomized Control Trial (RCT) with 1:1 randomization of adults newly diagnosed with type 2 diabetes (T2D) to Routine Care (RC) and RC + Glycemic Excursion Minimization (RC+GEM); a program that provides RC in addition to continuous glucose monitors (CGM) within a structured, self-directed, and per...

What is the current status of trial NCT05766735?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-08-08. Estimated completion is 2027-04-15.

What conditions does trial NCT05766735 study?

This clinical trial studies the following conditions: Type 2 Diabetes.

What interventions are being tested in trial NCT05766735?

The interventions under investigation include: Routine Care + Glycemic Excursion Minimization (RC+GEM) (BEHAVIORAL), Routine Care (RC) (OTHER).

Who is sponsoring clinical trial NCT05766735?

This trial is sponsored by Chiara Fabris, PhD, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05766735 being conducted?

This trial has 2 study locations across Colorado, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.